Jérôme Rey

3.4k total citations
76 papers, 1.4k citations indexed

About

Jérôme Rey is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, Jérôme Rey has authored 76 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Hematology, 28 papers in Genetics and 19 papers in Oncology. Recurrent topics in Jérôme Rey's work include Acute Myeloid Leukemia Research (31 papers), Immune Cell Function and Interaction (17 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (15 papers). Jérôme Rey is often cited by papers focused on Acute Myeloid Leukemia Research (31 papers), Immune Cell Function and Interaction (17 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (15 papers). Jérôme Rey collaborates with scholars based in France, Italy and United States. Jérôme Rey's co-authors include Norbert Vey, Daniel Olive, Aude Charbonnier, Julien Mozziconacci, Anne Murati, Daniel Birnbaum, Evelyne D’Incan, Cyril Fauriat, Régis Costello and Véronique Gelsi‐Boyer and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Jérôme Rey

75 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jérôme Rey France	22	605	596	527	347	307	76	1.4k
Monic J. Stuart United States	15	443 0.7×	953 1.6×	456 0.9×	431 1.2×	179 0.6×	26	1.5k
Michael J. Clemente United States	20	773 1.3×	412 0.7×	469 0.9×	217 0.6×	205 0.7×	67	1.5k
Ana Rasillo Spain	20	259 0.4×	992 1.7×	597 1.1×	302 0.9×	560 1.8×	22	1.5k
Paloma Bárcena Spain	19	372 0.6×	309 0.5×	348 0.7×	198 0.6×	158 0.5×	24	859
Mireia Camós Spain	22	329 0.5×	576 1.0×	500 0.9×	547 1.6×	502 1.6×	57	1.8k
Édouard Forcade France	18	372 0.6×	674 1.1×	195 0.4×	441 1.3×	138 0.4×	105	1.2k
Prajwal Boddu United States	21	160 0.3×	734 1.2×	361 0.7×	371 1.1×	373 1.2×	51	1.2k
Maurizio Miglino Italy	18	291 0.5×	737 1.2×	260 0.5×	319 0.9×	220 0.7×	65	1.1k
Ingrid Simonitsch Austria	22	361 0.6×	365 0.6×	244 0.5×	357 1.0×	327 1.1×	54	1.4k
MF Martelli Italy	15	506 0.8×	405 0.7×	214 0.4×	376 1.1×	229 0.7×	30	1.2k

Countries citing papers authored by Jérôme Rey

Since Specialization

Citations

This map shows the geographic impact of Jérôme Rey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jérôme Rey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jérôme Rey more than expected).

Fields of papers citing papers by Jérôme Rey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jérôme Rey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jérôme Rey. The network helps show where Jérôme Rey may publish in the future.

Co-authorship network of co-authors of Jérôme Rey

This figure shows the co-authorship network connecting the top 25 collaborators of Jérôme Rey. A scholar is included among the top collaborators of Jérôme Rey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jérôme Rey. Jérôme Rey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Barraco, Fiorenza, Jean‐Christophe Ianotto, Éric Jourdan, et al.. (2023). Advances in management of primary myelofibrosis and polycythaemia vera: Implications in clinical practice. SHILAP Revista de lepidopterología. 4(3). 779–791. 2 indexed citations

Petit, Claire, Bilal Mohty, Valério Maisano, et al.. (2023). Azacitidine–venetoclax versus azacitidine salvage treatment for primary induction failure or first relapsed acute myeloid leukaemia patients. European Journal Of Haematology. 112(4). 530–537. 7 indexed citations

Garciaz, Sylvain, Colombe Saillard, Yosr Hicheri, et al.. (2022). Azacitidine Plus Venetoclax for the Treatment of Relapsed and Newly Diagnosed Acute Myeloid Leukemia Patients. Cancers. 14(8). 2025–2025. 36 indexed citations

Zemmour, Christophe, Jérôme Rey, Aude Charbonnier, et al.. (2020). Post-remission therapy of adults aged 60 and older with acute myeloid leukemia in first complete remission: role of treatment intensity on the outcome. Annals of Hematology. 99(4). 773–780. 6 indexed citations

Eisinger, François, Evelyne D’Incan, Jérôme Rey, et al.. (2020). Socioeconomic deprivation is associated with decreased survival in patients with acute myeloid leukemia. Cancer Epidemiology. 66. 101699–101699. 8 indexed citations

Venton, Geoffroy, Lauris Gastaud, Lionel Mannone, et al.. (2019). Alternative Effective and Safe Induction Regimens for Newly Diagnosed Acute Myeloid Leukemia in Patients With Cardiac Contraindication to Anthracyclines. Clinical Lymphoma Myeloma & Leukemia. 20(2). e76–e81. 2 indexed citations

Devillier, Raynier, Faézeh Legrand, Jérôme Rey, et al.. (2018). HLA-Matched Sibling versus Unrelated versus Haploidentical Related Donor Allogeneic Hematopoietic Stem Cell Transplantation for Patients Aged Over 60 Years with Acute Myeloid Leukemia: A Single-Center Donor Comparison. Biology of Blood and Marrow Transplantation. 24(7). 1449–1454. 30 indexed citations

Chrétien, Anne-Sophie, Cyril Fauriat, Florence Orlanducci, et al.. (2017). NKp30 expression is a prognostic immune biomarker for stratification of patients with intermediate-risk acute myeloid leukemia. Oncotarget. 8(30). 49548–49563. 34 indexed citations

Vey, Norbert, Thomas Prébet, Claire Thalamas, et al.. (2016). Phase 1 dose-escalation study of oral abexinostat for the treatment of patients with relapsed/refractory higher-risk myelodysplastic syndromes, acute myeloid leukemia, or acute lymphoblastic leukemia. Leukemia & lymphoma. 58(8). 1880–1886. 15 indexed citations

10.

Legros, Laurence, et al.. (2015). Les mutations de la calréticuline, une nouvelle aide pour le diagnostic des syndromes myéloprolifératifs. La Revue de Médecine Interne. 36(12). 791–793. 1 indexed citations

11.

Devillier, Raynier, Sabine Fürst, Roberto Crocchiolo, et al.. (2014). Poor Outcome with Nonmyeloablative Conditioning Regimen before Cord Blood Transplantation for Patients with High-Risk Acute Myeloid Leukemia Compared with Matched Related or Unrelated Donor Transplantation. Biology of Blood and Marrow Transplantation. 20(10). 1560–1565. 8 indexed citations

12.

Ianotto, Jean‐Christophe, Emmanuel Gyan, Kamel Laribi, et al.. (2013). Efficacy and safety of pegylated‐interferon α‐2a in myelofibrosis: a study by the FIM and GEM French cooperative groups. British Journal of Haematology. 162(6). 783–791. 57 indexed citations

13.

Devillier, Raynier, Sabine Fürst, Jean El Cheikh, et al.. (2013). Antithymocyte Globulin in Reduced-Intensity Conditioning Regimen Allows a High Disease-Free Survival Exempt of Long-Term Chronic Graft-versus-Host Disease. Biology of Blood and Marrow Transplantation. 20(3). 370–374. 34 indexed citations

14.

Brecqueville, Mandy, Jérôme Rey, François Bertucci, et al.. (2012). Mutation analysis of ASXL1, CBL, DNMT3A, IDH1, IDH2, JAK2, MPL, NF1, SF3B1, SUZ12, and TET2 in myeloproliferative neoplasms. Genes Chromosomes and Cancer. 51(8). 743–755. 113 indexed citations

15.

Aurran‐Schleinitz, Thérèse, Rémy Castellano, Jérôme Rey, et al.. (2012). Primary B-CLL Resistance to NK Cell Cytotoxicity can be Overcome In Vitro and In Vivo by Priming NK Cells and Monoclonal Antibody Therapy. Journal of Clinical Immunology. 32(3). 632–646. 44 indexed citations

16.

Costello, Régis, Cyril Fauriat, Jérôme Rey, Jean‐Albert Gastaut, & Daniel Olive. (2003). Immunobiology of haematological malignant disorders: the basis for novel immunotherapy protocols. The Lancet Oncology. 5(1). 47–55. 9 indexed citations

17.

Rey, Jérôme, et al.. (2001). [Spinal cord compression caused by extramedullary hematopoiesis foci in the course of thalassemia].. PubMed. 30(27). 1351–3. 4 indexed citations

18.

Granel, B., Jacques Serratrice, Jérôme Rey, et al.. (1999). Livedo reticularis revealing a latent infective endocarditis due to Coxiella burnetti. Journal of the American Academy of Dermatology. 41(5). 842–844. 8 indexed citations

19.

Dinh‐Xuan, Anh Tuan, Jacques Regnard, Thomas Similowski, et al.. (1990). Effects of SK&F 104353, a leukotriene receptor antagonist, on the bronchial responses to histamine in subjects with asthma: A comparative study with terfenadine. Journal of Allergy and Clinical Immunology. 85(5). 865–871. 9 indexed citations

20.

Vannier, J.P., F Arnaud‐Battandier, C. Ricour, et al.. (1982). Neutropénie primitive et congénitale et maladie de Crohn. A propos de deux observations chez l'enfant.. 39(6). 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact